Frontier Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Frontier Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$6.95M	Sell	90,204 -1,086	-1%	-$82.7K	0.5%	52
2022 Q1	$6.99M	Buy	91,290 +3,934	+5%	+$264K	0.09%	46
2021 Q4	$5.45M	Sell	87,356 -12,566	-13%	-$737K	0.36%	56
2021 Q3	$5.91M	Sell	99,922 -3,955	-4%	-$260K	0.41%	51
2021 Q2	$6.94M	Buy	103,877 +470	+0.5%	+$30.6K	0.49%	39
2021 Q1	$6.53M	Sell	103,407 -1,916	-2%	-$119K	0.5%	39
2020 Q4	$6.53M	Buy	105,323 +245	+0.2%	+$15.1K	0.53%	35
2020 Q3	$6.33M	Buy	105,078 +1,975	+2%	+$119K	0.58%	33
2020 Q2	$6.06M	Buy	103,103 +4,615	+5%	+$276K	0.56%	35
2020 Q1	$5.49M	Buy	98,488 +38,251	+64%	+$2.34M	0.9%	33
2019 Q4	$3.87M	Buy	60,237 +33,409	+125%	+$1.91M	0.62%	41
2019 Q3	$1.36M	Sell	26,828 -755	-3%	-$35.5K	0.2%	108
2019 Q2	$1.25M	Sell	27,583 -13,404	-33%	-$624K	0.18%	105
2019 Q1	$1.96M	Buy	40,987 +8,257	+25%	+$411K	0.27%	86
2018 Q4	$1.7M	Buy	32,730 +112	+0.3%	+$6.02K	0.26%	94
2018 Q3	$2.02M	Sell	32,618 -17	-0.1%	-$1.01K	0.19%	84
2018 Q2	$1.81M	Buy	32,635 +301	+0.9%	+$16.3K	0.26%	88
2018 Q1	$2.04M	Buy	32,334 +5,842	+22%	+$376K	0.29%	87
2017 Q4	$1.62M	Sell	26,492 -9,831	-27%	-$615K	0.26%	90
2017 Q3	$2.31M	Sell	36,323 -319	-0.9%	-$18.6K	0.33%	81
2017 Q2	$2.04M	Sell	36,642 -284	-0.8%	-$15.5K	0.31%	86
2017 Q1	$2.01M	Sell	36,926 -2,408	-6%	-$132K	0.31%	88
2016 Q4	$2.3M	Buy	39,334 +12,416	+46%	+$679K	0.38%	75
2016 Q3	$1.45M	Sell	26,918 -2,004	-7%	-$129K	0.22%	110
2016 Q2	$2.13M	Sell	28,922 -84	-0.3%	-$5.93K	0.34%	80
2016 Q1	$1.85M	Buy	29,006 +20	+0.1%	+$1.26K	0.16%	90
2015 Q4	$1.99M	Sell	28,986 -500	-2%	-$33K	0.32%	87
2015 Q3	$1.75M	Buy	29,486 +1,418	+5%	+$90K	0.28%	95
2015 Q2	$1.87M	Buy	28,068 +7,173	+34%	+$473K	0.29%	85
2015 Q1	$1.35M	Buy	20,895 +9,662	+86%	+$605K	0.22%	87
2014 Q4	$663K	Buy	+11,233	New	+$633K	0.12%	114

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Frontier Wealth Management's BMY Position: Q2 2022 in Review

Frontier Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2022, selling an estimated $82.7K and leaving 90,204 shares worth $6.95M. The position accounts for 0.5% of the portfolio, ranked #52.

Frontier Wealth Management first reported a position in BMY in Q4 2014 and has held it in 31 quarters since. The position peaked at $6.99M in Q1 2022. 2,540 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Frontier Wealth Management held 90,204 shares of Bristol-Myers Squibb worth $6.95M as of Q2 2022.
Frontier Wealth Management sold 1,086 Bristol-Myers Squibb shares in Q2 2022, an estimated $82.7K.
Bristol-Myers Squibb made up 0.5% of Frontier Wealth Management's portfolio in Q2 2022, its #52 holding.
Frontier Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 31 quarters since.
Frontier Wealth Management's Bristol-Myers Squibb position peaked at $6.99M in Q1 2022.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Frontier Wealth Management's 13F filing for Q2 2022, filed 12 Aug 2022.